Medical Historical Balance Sheet

MVP Stock

0.42 0.01 2.33%

Trend analysis of Medical Developments International balance sheet accounts such as Total Stockholder Equity of 28.2 M provides information on Medical Developments' total assets, liabilities, and equity, which is the actual value of Medical Developments to its prevalent stockholders. By breaking down trends over time using Medical Developments balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Medical Developments latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medical Developments is a good buy for the upcoming year.

Medical Developments Inventory

9.21 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Developments International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Medical Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Medical Developments at a specified time, usually calculated after every quarter, six months, or one year. Medical Developments Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medical Developments and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medical currently owns. An asset can also be divided into two categories, current and non-current.

Medical Developments Balance Sheet Chart

At this time, Medical Developments' Property Plant And Equipment Gross is comparatively stable compared to the past year. Short Term Debt is likely to gain to about 494.4 K in 2024, whereas Total Stockholder Equity is likely to drop slightly above 28.2 M in 2024.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Medical Developments assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medical Developments books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Medical Developments balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Medical Developments International are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Medical Developments' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Medical Developments current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Developments International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	2.8M	2.6M	2.3M	2.7M
Total Assets	101.4M	109.5M	59.2M	44.3M

Short Long Term Debt Total Total Assets

Medical Developments balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Other Current Liab	Other Liab	Current Deferred Revenue
Total Assets		0.04	0.84	0.94	0.89	-0.84	0.66	0.89	0.91	0.89	0.73	0.8	0.69	0.06	0.73	0.69	0.05	0.87	0.73	0.94	-0.51	0.37	0.59	0.44	0.68	0.42
Short Long Term Debt Total	0.04		-0.02	-0.03	0.19	0.31	0.02	-0.12	0.12	-0.12	-0.06	-0.03	-0.01	0.01	0.27	0.08	-0.24	0.13	0.11	-0.11	0.1	0.1	0.0	0.14	-0.04	0.07
Total Current Liabilities	0.84	-0.02		0.84	0.74	-0.61	0.8	0.65	0.75	0.65	0.81	0.67	0.78	-0.01	0.42	0.7	0.35	0.66	0.69	0.8	-0.43	0.32	0.61	0.23	0.37	0.35
Total Stockholder Equity	0.94	-0.03	0.84		0.83	-0.86	0.76	0.9	0.87	0.9	0.77	0.79	0.81	-0.01	0.58	0.74	-0.01	0.65	0.79	0.96	-0.41	0.4	0.71	0.21	0.42	0.19
Property Plant And Equipment Net	0.89	0.19	0.74	0.83		-0.67	0.75	0.73	0.84	0.73	0.85	0.91	0.76	-0.31	0.68	0.87	-0.06	0.78	0.91	0.82	-0.56	0.65	0.78	0.37	0.55	0.49
Net Debt	-0.84	0.31	-0.61	-0.86	-0.67		-0.48	-0.98	-0.68	-0.98	-0.59	-0.73	-0.56	-0.01	-0.48	-0.53	-0.04	-0.62	-0.61	-0.94	0.37	-0.29	-0.56	-0.3	-0.57	-0.19
Accounts Payable	0.66	0.02	0.8	0.76	0.75	-0.48		0.49	0.72	0.49	0.86	0.77	0.86	-0.44	0.39	0.91	0.06	0.38	0.89	0.64	-0.33	0.62	0.88	-0.22	0.0	0.08
Cash	0.89	-0.12	0.65	0.9	0.73	-0.98	0.49		0.74	1.0	0.59	0.74	0.59	0.06	0.56	0.55	0.0	0.69	0.64	0.97	-0.37	0.29	0.55	0.36	0.61	0.22
Non Current Assets Total	0.91	0.12	0.75	0.87	0.84	-0.68	0.72	0.74		0.74	0.6	0.73	0.68	0.03	0.88	0.73	-0.02	0.77	0.73	0.81	-0.36	0.52	0.6	0.21	0.5	0.24
Cash And Short Term Investments	0.89	-0.12	0.65	0.9	0.73	-0.98	0.49	1.0	0.74		0.59	0.73	0.59	0.06	0.56	0.54	0.0	0.68	0.64	0.97	-0.36	0.29	0.55	0.36	0.61	0.22
Net Receivables	0.73	-0.06	0.81	0.77	0.85	-0.59	0.86	0.59	0.6	0.59		0.84	0.8	-0.45	0.26	0.85	0.05	0.53	0.88	0.72	-0.51	0.52	0.84	0.17	0.27	0.37
Common Stock Total Equity	0.8	-0.03	0.67	0.79	0.91	-0.73	0.77	0.74	0.73	0.73	0.84		0.82	-0.52	0.55	0.91	-0.08	0.63	0.92	0.8	-0.44	0.77	0.9	0.14	0.44	0.31
Common Stock Shares Outstanding	0.69	-0.01	0.78	0.81	0.76	-0.56	0.86	0.59	0.68	0.59	0.8	0.82		-0.35	0.35	0.87	-0.01	0.38	0.86	0.73	-0.35	0.66	0.87	-0.09	0.1	0.14
Short Term Investments	0.06	0.01	-0.01	-0.01	-0.31	-0.01	-0.44	0.06	0.03	0.06	-0.45	-0.52	-0.35		0.09	-0.62	0.04	0.15	-0.56	0.01	0.1	-0.73	-0.69	0.35	0.27	0.0
Non Current Liabilities Total	0.73	0.27	0.42	0.58	0.68	-0.48	0.39	0.56	0.88	0.56	0.26	0.55	0.35	0.09		0.5	-0.08	0.77	0.5	0.57	-0.25	0.46	0.33	0.27	0.6	0.24
Inventory	0.69	0.08	0.7	0.74	0.87	-0.53	0.91	0.55	0.73	0.54	0.85	0.91	0.87	-0.62	0.5		0.04	0.47	0.98	0.67	-0.42	0.82	0.96	-0.07	0.16	0.22
Other Current Assets	0.05	-0.24	0.35	-0.01	-0.06	-0.04	0.06	0.0	-0.02	0.0	0.05	-0.08	-0.01	0.04	-0.08	0.04		0.14	-0.05	0.09	-0.28	-0.09	-0.04	0.14	0.11	0.29
Total Liab	0.87	0.13	0.66	0.65	0.78	-0.62	0.38	0.69	0.77	0.68	0.53	0.63	0.38	0.15	0.77	0.47	0.14		0.49	0.72	-0.53	0.26	0.3	0.66	0.9	0.65
Property Plant And Equipment Gross	0.73	0.11	0.69	0.79	0.91	-0.61	0.89	0.64	0.73	0.64	0.88	0.92	0.86	-0.56	0.5	0.98	-0.05	0.49		0.74	-0.43	0.77	0.96	-0.01	0.21	0.22
Total Current Assets	0.94	-0.11	0.8	0.96	0.82	-0.94	0.64	0.97	0.81	0.97	0.72	0.8	0.73	0.01	0.57	0.67	0.09	0.72	0.74		-0.45	0.36	0.65	0.34	0.58	0.29
Short Term Debt	-0.51	0.1	-0.43	-0.41	-0.56	0.37	-0.33	-0.37	-0.36	-0.36	-0.51	-0.44	-0.35	0.1	-0.25	-0.42	-0.28	-0.53	-0.43	-0.45		-0.21	-0.33	-0.51	-0.5	-0.81
Intangible Assets	0.37	0.1	0.32	0.4	0.65	-0.29	0.62	0.29	0.52	0.29	0.52	0.77	0.66	-0.73	0.46	0.82	-0.09	0.26	0.77	0.36	-0.21		0.8	-0.14	0.05	0.16
Common Stock	0.59	0.0	0.61	0.71	0.78	-0.56	0.88	0.55	0.6	0.55	0.84	0.9	0.87	-0.69	0.33	0.96	-0.04	0.3	0.96	0.65	-0.33	0.8		-0.19	0.03	0.08
Other Current Liab	0.44	0.14	0.23	0.21	0.37	-0.3	-0.22	0.36	0.21	0.36	0.17	0.14	-0.09	0.35	0.27	-0.07	0.14	0.66	-0.01	0.34	-0.51	-0.14	-0.19		0.79	0.79
Other Liab	0.68	-0.04	0.37	0.42	0.55	-0.57	0.0	0.61	0.5	0.61	0.27	0.44	0.1	0.27	0.6	0.16	0.11	0.9	0.21	0.58	-0.5	0.05	0.03	0.79		0.67
Current Deferred Revenue	0.42	0.07	0.35	0.19	0.49	-0.19	0.08	0.22	0.24	0.22	0.37	0.31	0.14	0.0	0.24	0.22	0.29	0.65	0.22	0.29	-0.81	0.16	0.08	0.79	0.67

Click cells to compare fundamentals

Medical Developments Account Relationship Matchups

Medical Developments balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	94.9M	100.2M	101.4M	109.5M	59.2M	44.3M
Short Long Term Debt Total	3.4M	3.0M	2.8M	2.6M	2.3M	2.7M
Total Current Liabilities	8.2M	7.0M	10.5M	15.5M	9.5M	5.1M
Total Stockholder Equity	43.3M	68.3M	57.3M	81.3M	45.7M	28.2M
Property Plant And Equipment Net	11.8M	11.7M	11.6M	12.1M	10.2M	10.7M
Net Debt	(12.2M)	(33.2M)	(17.6M)	(22.1M)	(7.4M)	(7.8M)
Accounts Payable	3.8M	3.3M	9.4M	13.3M	8.3M	8.7M
Cash	15.5M	36.3M	20.4M	24.7M	9.7M	7.9M
Non Current Assets Total	68.9M	52.8M	67.0M	66.7M	33.0M	24.1M
Cash And Short Term Investments	15.5M	36.3M	20.4M	24.7M	9.7M	7.9M
Net Receivables	4.1M	5.0M	6.2M	8.9M	7.1M	7.4M
Common Stock Shares Outstanding	67.0M	69.6M	72.4M	84.3M	88.6M	67.3M
Liabilities And Stockholders Equity	94.9M	100.2M	101.4M	109.5M	59.2M	44.6M
Non Current Liabilities Total	43.3M	24.9M	33.6M	12.6M	3.9M	7.1M
Inventory	5.9M	5.7M	7.1M	8.4M	8.8M	9.2M
Other Current Assets	416K	397K	620K	791K	565K	482.7K
Total Liab	51.5M	31.9M	44.1M	28.2M	13.4M	16.1M
Property Plant And Equipment Gross	11.8M	18.9M	20.1M	22.3M	22.7M	23.8M
Total Current Assets	26.0M	47.4M	34.4M	42.8M	26.1M	15.1M
Short Term Debt	417K	337K	348K	352K	371K	494.4K
Intangible Assets	16.1M	8.2M	8.0M	8.5M	19.0M	20.0M
Common Stock	41.0M	76.9M	77.0M	105.7M	121.6M	127.7M
Other Current Liab	4.0M	3.3M	683K	1.6M	639K	607.1K
Other Liab	30.3M	22.2M	22.0M	2.2M	2.6M	2.4M
Current Deferred Revenue	2.4M	68K	82K	283K	325.5K	508.4K
Retained Earnings	427K	(12.1M)	(24.5M)	(30.2M)	(62.9M)	(59.7M)
Other Assets	36.0M	35.1M	40.7M	8.1M	4.6M	4.4M
Accumulated Other Comprehensive Income	2.0M	3.5M	4.9M	5.7M	2.9M	3.0M
Property Plant Equipment	11.8M	11.7M	11.6M	12.1M	13.9M	14.6M
Non Currrent Assets Other	28.8M	30.6M	32.7M	29.9M	16.0M	16.8M
Net Tangible Assets	32.3M	62.3M	51.7M	75.7M	87.1M	91.4M
Deferred Long Term Liab	33.9M	32.8M	35.1M	32.7M	37.6M	24.5M
Long Term Debt Total	2.9M	2.7M	2.5M	2.2M	2.5M	2.6M
Net Invested Capital	43.4M	68.3M	57.3M	81.3M	45.7M	54.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medical Stock Analysis

When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC